SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-161661
Filing Date
2018-05-14
Accepted
2018-05-14 08:16:40
Documents
33
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d568127d10q.htm 10-Q 166840
2 EX-31.1 d568127dex311.htm EX-31.1 6713
3 EX-31.2 d568127dex312.htm EX-31.2 6690
4 EX-32.1 d568127dex321.htm EX-32.1 4886
  Complete submission text file 0001193125-18-161661.txt   1132725

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20180331.xml EX-101.INS 145315
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20180331.xsd EX-101.SCH 18448
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20180331_cal.xml EX-101.CAL 21150
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20180331_def.xml EX-101.DEF 28475
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20180331_lab.xml EX-101.LAB 150131
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20180331_pre.xml EX-101.PRE 95073
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 18828750
SIC: 2836 Biological Products, (No Diagnostic Substances)